Brian McVeigh

Brian McVeigh is a seasoned executive and entrepreneur in the biotechnology sector with a focus on delivering innovative genetic therapies. As Chairman, Chief Executive Officer, and Co-Founder of Code BioTherapeutics since April 2020, McVeigh has contributed to pioneering targeted delivery systems for genetic medicines. Concurrently, McVeigh serves as Executive Chairman and Co-Founder of 4BIO Capital, which specializes in advanced therapies, and holds leadership positions in several organizations including Genisphere, Araris Biotech AG, UPMC Enterprises, Longview Innovation, SciNeuro Pharmaceuticals, and SG3 Ventures LLC. A former Executive Chairman of Redpin Therapeutics, McVeigh successfully led the company through significant financing and a strategic exit. Educational credentials include a Bachelor of Science in Accounting and Finance from La Salle University, an MBA from Villanova University, and a Post-Master's Certificate in Pharmaceutical Marketing from Saint Joseph's University.